Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 24 min ago
Peer-reviewedCC BYBiosensors

Biosensing Platforms and Multimodal Monitoring of Sepsis-Associated Cell Death.

  • Oana Coman1,2
  • Leonard Azamfirei2
  • Oana Frandeș3
  • Bianca-Liana Grigorescu2
  1. 1Department of Simulation Applied in Medicine, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș, 540139 Târgu Mureș, Romania.
  2. 2Department of Anaesthesiology and Intensive Care, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș, 540139 Târgu Mureș, Romania.
  3. 3Doctoral School of Medicine and Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș, 540139 Târgu Mureș, Romania.
Read full textPDFDOICite

Abstract

Apoptosis plays an important role in sepsis-associated immune dysfunction, particularly through lymphocyte depletion and the development of persistent immunosuppression. This review examines apoptosis-associated biomarkers in sepsis, distinguishing relatively direct markers of cell death from complementary indicators of immune dysfunction, inflammation, and organ injury, and considers their potential for longitudinal monitoring. Particular attention is given to biosensing platforms that may enable rapid, low-volume, and multiplexed detection of these biomarkers. Representative electrochemical, optical, nanoparticle-assisted, and microfluidic approaches are discussed in terms of their analytical performance, biological relevance, and stage of clinical translation. The review also considers how serial biosensor measurements could be combined with physiological signals, conventional laboratory parameters, and organ dysfunction scores to follow changes in the patient's biological and clinical status over time. Artificial intelligence and machine-learning methods may facilitate the interpretation of these complex datasets and support multimodal patient assessment. However, most biosensors targeting relatively direct apoptosis-associated markers remain at the experimental stage, and their added clinical value in sepsis has not yet been established. Future studies should therefore determine whether serial assessment of cell-death-associated biomarkers provides meaningful information beyond currently available inflammatory biomarkers, physiological monitoring, and severity scores.

Related

  1. Early recognition of sepsis-associated acute kidney injury based on BioBERT-BPNN multimodal clinical data analysis
    Yufeng Chen, Hongyang Bian, Yuye Li
    PLOS OnePeer-reviewedCC BY 4.0Full textSystems & synthetic biologyEpidemiology & public healthPLOS
  2. Standardised procalcitonin monitoring and antibiotic duration in community-acquired sepsis: a pragmatic randomised controlled trial
    Thien Meensuk, Natthakit Chavapradit
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textEpidemiology & public healthCrossref
  3. Toward comprehensive multimodal health monitoring in heat: A digital biomarker exploration study
    N. Brasier, L. Schuepfer, C. Niederberger +2
    medRxivPreprintAll rights reservedFull textPhysiologymedRxiv
  4. Generative AI-powered multimodal physiological sensors for personalized edge health monitoring
    Ghadah Aldehim, Rajit Nair, Theyazn H. H. Aldhyani +5
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textCardiovascular medicineCrossref
  5. Dynamic trajectories of sepsis-induced immunoparalysis: from biological mechanisms to precision monitoring and targeted intervention
    Chengxin Xue, Yiheng Hu, Xinyun Wu +5
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@article{coman2026biosensing,
  title = {{Biosensing Platforms and Multimodal Monitoring of Sepsis-Associated Cell Death.}},
  author = {Oana Coman and Leonard Azamfirei and Oana Frandeș and Bianca-Liana Grigorescu},
  journal = {Biosensors},
  year = {2026},
  month = sep,
  doi = {10.3390/bios16100531},
  url = {https://europepmc.org/article/MED/42930077},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Biosensing Platforms and Multimodal Monitoring of Sepsis-Associated Cell Death.
AU  - Oana Coman
AU  - Leonard Azamfirei
AU  - Oana Frandeș
AU  - Bianca-Liana Grigorescu
PY  - 2026
DA  - 2026/09/23
JO  - Biosensors
DO  - 10.3390/bios16100531
UR  - https://europepmc.org/article/MED/42930077
AB  - Apoptosis plays an important role in sepsis-associated immune dysfunction, particularly through lymphocyte depletion and the development of persistent immunosuppression. This review examines apoptosis-associated biomarkers in sepsis, distinguishing relatively direct markers of cell death from complementary indicators of immune dysfunction, inflammation, and organ injury, and considers their potential for longitudinal monitoring. Particular attention is given to biosensing platforms that may enable rapid, low-volume, and multiplexed detection of these biomarkers. Representative electrochemical, optical, nanoparticle-assisted, and microfluidic approaches are discussed in terms of their analytical performance, biological relevance, and stage of clinical translation. The review also considers how serial biosensor measurements could be combined with physiological signals, conventional laboratory parameters, and organ dysfunction scores to follow changes in the patient's biological and clinical status over time. Artificial intelligence and machine-learning methods may facilitate the interpretation of these complex datasets and support multimodal patient assessment. However, most biosensors targeting relatively direct apoptosis-associated markers remain at the experimental stage, and their added clinical value in sepsis has not yet been established. Future studies should therefore determine whether serial assessment of cell-death-associated biomarkers provides meaningful information beyond currently available inflammatory biomarkers, physiological monitoring, and severity scores.
SN  - 2079-6374
ER  -